AI Summary & Key Takeaways
AI InsightAlthough it was well tolerated, the risks of longterm use of the doses which were higher than the traditional Asian diet is currently unclear.
📌 3 Key Takeaways
Abstract
Objective: To determine the effect of standardized soy isoflavones (Super Concentrated Isoflavones, Solgar, Türkiye), added to diet as an alternative modality, on menopausal complaints. Materials and methods: Thirty-eight healthy women who had amenorrhea and menopausal complaints -at least 12 months and did not accept hormone replacement therapy were included in the trial. The participants had 38 mg/day soy isoflavones (Daidzain: 18 mg, Gfycitein: 15 mg, Genistein: 5.5 mg) for 16 weeks in their diets. The efficacy was evaluated by the changes obtained in Greene Climacteric Scale scores at the beginning and at the end of the trial. Results: When the changes in menopausal symptoms were evaluated before and at the end of 16 weeks of soy isoflavons use; the anxiety symptom score (10,52 ±4,79 I 7,76 ±4,59), depression symptom score (4,65 ±3,44 I 3,34 ± 3.03), somatic symptom score (7,47 ±4,601 4,89 ±3,89), vasomotor symptom score (4,34 ±1,53 I 2,31 ±1,59) and sexual dysfunction score (1,84 ±1,15/1,52 ±1,08) showed statistically significant decreases (pO.OOl). Conclusion : We showed that the addition of 38 mg/day soy isoflavones in the diet significantly decreases menopausal symptoms. According to the findings of relieving the menopausal complaints, we advise to consider Super Concentrated Isoflavones as an alternative to the conventional hormone replacement therapies inpostmenopausal women, in this trial we determined that isoflavones are effective on anxiety symptom score, depression symptom score, somatic symptom score, vasomotor symptom score and sexual dysfunction score. We did not find any difference in endometrial thickness and vaginal citilogy before and after the treatment. Although it was well tolerated, the risks of longterm use of the doses which were higher than the traditional Asian diet is currently unclear.
Özet
Amaç: Alternatif tedavi modalitesi olarak, standardize edilmiş soya İsoflavonlannın (SuperConcentratedIsoflavones, Solgar, Türkiye) diyete eklenmesinin menopozal şikayetler üzerine olan etkisini araştırmak. Gereç ve yöntem: En az 12 aydır amenoresi olan ve menopozal şikayetleri bulunan, hormon replasman tedavisini kabul etmeyen 38 sağlıklı kadın çalışmaya alındı. Katılımcıların diyetlerine 16 hafta süresince 38 mg / gün soya isoflavonlan (Daidzain: 18 mg, Glycitein: 15 mg, Genistein: 5.5 mg ) eklendi. Etkinliğin değerlendirilmesi, çalışmanın başlangıcında ve sonunda Greene Climacteric Scale skorundaM değişiklikler ölçülerek yapıldı. Bulgular: Menopozal semptomlardaki değişiklikler soy isoflavonlann 16 haftalık kullanımı öncesi ve sonrasında değerlendirildiğinde; anksiyete semptom skoru (10,52 ±4,79/7,76 ±4,59), depresyon semptom skoru (4,65 ±3,44/3,34 ±3.03), somatik semptom skora (7,47 ±4,60/4,89 ±3,89), vazomotor semptom skoru (4,34 ±1,53/2,31 ±1,59) ve seksüel fonksiyon bozukluğu skoru (1,84 ±1,15/1,52 ± 1,08) istatistiksel olarak anlamlı düşüşler göstermiştir (p